Jianning Zhang MD, Ph.D
Chairman, VII Chinese Medical Association of Neurosurgery, China
Chairman, II Tianjin Medical Association of Neurosurgery, China
President, Tianjin Medical University General Hospital, China
Director, Tianjin Neurological Institute, China
Senior Consultant, Neurosurgery and Neurology Department, Montreal Neurological Institute and Hospital, Canada
After graduating from medical school in 1982, Professor Zhang has devoted the past 30 years to clinical service, research and education in the field of Neurological Surgery. His professional training includes fellowships in Kurume University in Japan and in Baylor College of Medicine in the United States.
He has performed more than 3,500 different types of neurosurgical operations. He is one of the renowned neurosurgeon in China with specialization in minimally invasive surgical treatment of spinal cord disease, comprehensive treatment of traumatic brain injury and pituitary adenomas.
He devoted himself to understanding the underlying pathogenesis of Traumatic Brain Injury (TBI) and seeking effective treatments. He pinpointed the essential mechanism of discrepancy between traumatic brain injury and spinal cord injury after early high-dose glucocorticoids treatment, and created a stress-function-centered guideline of optimum glucocorticoids treatment. He also firstly described the dynamic changes of endothelial progenitor cells, and its correlation with blood-brain-barrier leakage and TBI prognosis. His work demonstrated VEGI as a potential therapeutic agent to repair blood-brain-barrier damage and restore neurological function. His pioneering research also includes firstly illustrating that brain-derived microparticles induce TBI coagulopathy.